http://verygoodnewsisrael.blogspot.com/
ISRAEL’S MEDICAL ACHIEVEMENTS
Leukemia treatment extends to solid tumors. (TY UWI) Tel Aviv University scientists have engineered the successful Israel-invented CAR-T cell therapy (see here) to also treat other cancers. They discovered a subset of immune system T cells (known as CD4+ T cells) will attract antibodies on solid tumors and destroy them.
https://www.jpost.com/HEALTH-SCIENCE/Israeli-blood-cancer-treatment-could-also-kill-solid-tumors-new-study-603934 https://www.israel21c.org/engineered-t-cells-could-assassinate-solid-tumor-cells/
Breakthrough in search for a vaccine against Ebola. (TY UWI) Scientists at Israel’s Weizmann Institute working with researchers in Germany have identified two antibodies that are effective in stopping one species of the Ebola virus. Research is ongoing to developing a multi-species vaccine.
https://www.israel21c.org/experimental-ebola-vaccine-offers-long-term-protection/
Another blood test for lung cancer. A team of Israeli (Weizmann Institute) and British scientists have devised a blood test that analyzes activity of three enzymes (OGG1, MPG and APE1) connected to DNA damage. They say it can “significantly improve current lung cancer risk prediction, assisting prevention and early detection.”
http://nocamels.com/2019/10/israel-british-scientists-blood-test-lung-cancer-screening/
http://www.weizmann.ac.il/WeizmannCompass/sections/briefs/dna%E2%80%99s-smoking-gun
Good trial results for presbyopia treatment. (TY WIN) As reported previously (Sep 2018) Israel’s Orasis has developed CSF-1 (eye drops) to treat presbyopia – age-related far-sightedness. Results of Phase 2b trials of CSF-1 showed “significant improvement”, together with “exceptional safety and tolerability”.
https://www.orasis-pharma.com/orasis-pharmaceuticals-announces-csf-1-eye-drop-successfully-met-primary-endpoint-in-phase-2b-clinical-study-in-presbyopia/
The signature of cancer cells. Researchers at Israel’s Technion Institute have used artificial intelligence and big data to decode the unique signatures of certain cancer cells. The resulting technology – dubbed a “computerized pathologist” –could significantly boost development of personalized cancer treatments.
https://www.israel21c.org/deep-learning-tech-reveals-personal-id-of-cancer-cells/
Israeli cancer survival rates rise significantly. Five-year survival rates for Israelis (Jews & Arabs) diagnosed with all types of invasive cancers have increased significantly over the last decade. For example, of Jewish women diagnosed in 1996 only 63% survived five years or more. From 2011 this rose to 71%.
https://www.jpost.com/Israel-News/Cancer-survival-rates-among-Israelis-rise-significantly-over-last-decade-605547
New Israeli record for blood donations. (TY UWI) Israelis donated 1,567units of blood in one day at the Magen David Adom station at the Samaria Regional Division. They broke the previous Israeli record of 740 units in a 2014 Tel Aviv session. Donors included residents and soldiers from the IDF’s Samaria Division.
http://www.israelnationalnews.com/News/News.aspx/269823
Closing openings in Panama. (TY Atid-EDI) Israel’s Gordian Surgical is to provide thousands of its TroClose1200 access-closure systems to public hospitals in Panama. Gordian’s distributor PanaFarma won the tender to supply the post-operation surgical closure system (see here) to Panama’s social security hospitals.
https://www.prnewswire.com/news-releases/gordian-surgicals-closure-system-used-in-panama-by-panafarma-300929570.html
What the microbiome has taught us. Dr Elan Elinav and Prof Elan Segal of Israel’s Weizmann Institute have made many medical discoveries from microbiome (gut bacteria) research. They include artificial sweeteners’ link to obesity / diabetes and gut microbes’ impact on ALS. There are 40 scientists in their research lab.
https://www.israel21c.org/is-the-microbiome-about-to-change-medicine-for-good/